Clinical Trials Logo

Recurrence clinical trials

View clinical trials related to Recurrence.

Filter by:

NCT ID: NCT01295853 Completed - Recurrence Clinical Trials

T3 Versus T4 Sympathicotomy for Treatment of Primary Palmar Hyperhidrosis

Start date: February 2008
Phase: N/A
Study type: Interventional

T3 versus T4 as a primary treatment for palmer hyperhydrosis and effect on postoperative compensatory hyperhydrosis

NCT ID: NCT01295437 Completed - Chronic Pain Clinical Trials

Comparison of Three Meshes in Lichtenstein Hernia Repair

Lichtenstein
Start date: March 2003
Phase: N/A
Study type: Interventional

Chronic pain may be a long-term problem after inguinal Lichtenstein hernioplasty. The aim of this study was to compare long-term results of hernioplasty using three different meshes (partly absorbable, lightweight polypropylene and thick polypropylene mesh).

NCT ID: NCT01294735 Completed - Melanoma Clinical Trials

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Start date: February 2011
Phase: Phase 1
Study type: Interventional

This is a non-randomized two-part study of MK-4827 given with temozolomide in participants with advanced cancer. In Part A of the study, the dose-limiting toxicities (DLTs) and the maximum tolerated dose (MTD) of MK-4827 when combined with temozolomide will be found by increasing the MK-4827 dose level in successive cohorts. In Part B of the study, participants with advanced glioblastoma multiforme and advanced melanoma will be enrolled to further evaluate the tolerability and efficacy of the MK-4827 + temozolomide combination.

NCT ID: NCT01291511 Completed - Schizophrenia Clinical Trials

Relapse Prevention Study in Patients With Schizophrenia

REPRIEVE
Start date: February 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether Iloperidone is effective in the prevention of relapse in patients with schizophrenia

NCT ID: NCT01287728 Completed - Clinical trials for Abnormal Vaginal Flora

The Value of Bacterial Loads by Real Time PCR in Predicting Recurrence of Abnormal Vaginal Flora After Oral Metronidazole Therapy

Start date: January 2011
Phase: Phase 3
Study type: Interventional

Abnormal vaginal flora is currently diagnosed among women (20-40%). It is associated with symptoms (bad smell, vaginal discharge) and adverse out-comes in pregnant and not pregnant women. The high recurrence rate raises the long-term effectiveness of therapy. The hypothesis is the persistence of bacteria associated with vaginal flora imbalance as Atopobium vaginae and Gardnerella vaginalis. At the present time there is a lack of an accurate marker for the risk of recurrence.

NCT ID: NCT01282593 Completed - Clinical trials for Acute Lymphoblastic Leukemia (ALL)

Potential Role of CD9 and Implication of Motility Process in Pathogenesis of TEL/ALM1-positive ALL Relapses (LAL TEL/ALM1 and CD9).

LAL TEL/ALM1
Start date: November 2010
Phase: N/A
Study type: Interventional

Down regulation of CD9 in TEL/AML1-positive ALL is addressed in motility assays to explore its role in B-ALL pathogenesis and its potential implication in relapses (and prognosis).

NCT ID: NCT01268150 Completed - Clinical trials for Metastatic Breast Cancer ( HER2 Negative)

A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast Cancer

Start date: February 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of single-agent eribulin mesylate for first-line treatment of subjects with locally recurrent or metastatic breast cancer.

NCT ID: NCT01257152 Completed - Breast Neoplasms Clinical Trials

Screening MRI for Cancer Recurrence in Patients Treated With Breast Conserving Therapy

Start date: December 2010
Phase: N/A
Study type: Observational

A prospective, multicenter study: - Primary objective: to assess the diagnostic yield of screening MRI compared to physical examination, mammography or ultrasonography in the detection of recurrence in patients treated with breast conserving therapy - Secondary objective: to describe the size, type, grade, and nodal status of cancers seen only on MRI and to estimate the rate of benign biopsies and short interval follow-up induced only by MRI in this population.

NCT ID: NCT01235130 Completed - Atrial Fibrillation Clinical Trials

Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation

AFFORD
Start date: March 2009
Phase: Phase 3
Study type: Interventional

The general objective of this study is to demonstrate the effectiveness of n-3 fatty acids, 2.4 grams per day, to prevent recurrence of atrial fibrillation in patients with paroxysmal or persistent AF in whom a rhythm-control strategy is planned.

NCT ID: NCT01229475 Recruiting - Atrial Fibrillation Clinical Trials

Stepwise Approach Versus Linear Ablation in Patients With Recurrence of Persistent Atrial Fibrillation

REDO-AF
Start date: October 2010
Phase: N/A
Study type: Interventional

Catheter ablation of persistent atrial fibrillation (AF) remains a challenging procedure. Even in experienced centres, repeat interventions are necessary in up to 70 of patients to achieve sinus rhythm at a long-term follow-up. While there is a consensus to perform pulmonary vein isolation (PVI) as a cornerstone for the ablation of paroxysmal and persistent AF ablation, different additional ablation strategies are used to achieve a modification of the substrate that perpetuates the arrhythmia: linear lesions (anterior and roof lines) or ablation of complex fractionated atrial electrograms (CFAE). In the stepwise approach PVI, CFAE ablation and/or LL are combined according to the presenting arrhythmia during procedure. The aim of the study is to determine whether there is a difference in terms of freedom from arrhythmia between a stepwise approach and a linear ablation for repeat procedure in patient with recurrence of persistent atrial fibrillation.